185 related articles for article (PubMed ID: 38509729)
21. Synthetic growth hormone-releasing hormone agonist ameliorates the myocardial pathophysiology characteristic of heart failure with preserved ejection fraction.
Dulce RA; Kanashiro-Takeuchi RM; Takeuchi LM; Salerno AG; Wanschel ACBA; Kulandavelu S; Balkan W; Zuttion MSSR; Cai R; Schally AV; Hare JM
Cardiovasc Res; 2023 Feb; 118(18):3586-3601. PubMed ID: 35704032
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts.
Li L; Fan D; Wang C; Wang JY; Cui XB; Wu D; Zhou Y; Wu LL
Cardiovasc Res; 2011 Jul; 91(1):80-9. PubMed ID: 21367774
[TBL] [Abstract][Full Text] [Related]
23. Hydrochlorothiazide modulates ischemic heart failure-induced cardiac remodeling via inhibiting angiotensin II type 1 receptor pathway in rats.
Luo J; Chen X; Luo C; Lu G; Peng L; Gao X; Zuo Z
Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 28039944
[TBL] [Abstract][Full Text] [Related]
24. Prevention of heart failure with preserved ejection fraction (HFpEF): reexamining microRNA-21 inhibition in the era of oligonucleotide-based therapeutics.
Ben-Nun D; Buja LM; Fuentes F
Cardiovasc Pathol; 2020; 49():107243. PubMed ID: 32629211
[TBL] [Abstract][Full Text] [Related]
25. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
[TBL] [Abstract][Full Text] [Related]
26. Crosstalk between the activated Slit2-Robo1 pathway and TGF-β1 signalling promotes cardiac fibrosis.
Liu Y; Yin Z; Xu X; Liu C; Duan X; Song Q; Tuo Y; Wang C; Yang J; Yin S
ESC Heart Fail; 2021 Feb; 8(1):447-460. PubMed ID: 33236535
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a robust mouse model of heart failure with preserved ejection fraction.
Matsiukevich D; Kovacs A; Li T; Kokkonen-Simon K; Matkovich SJ; Oladipupo SS; Ornitz DM
Am J Physiol Heart Circ Physiol; 2023 Aug; 325(2):H203-H231. PubMed ID: 37204871
[TBL] [Abstract][Full Text] [Related]
28. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling.
Liu N; He S; Ma L; Ponnusamy M; Tang J; Tolbert E; Bayliss G; Zhao TC; Yan H; Zhuang S
PLoS One; 2013; 8(1):e54001. PubMed ID: 23342059
[TBL] [Abstract][Full Text] [Related]
29. Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction.
Zhang L; Chen J; Yan L; He Q; Xie H; Chen M
Front Pharmacol; 2021; 12():646240. PubMed ID: 34177571
[No Abstract] [Full Text] [Related]
30. Effects of Kangdaxin on myocardial fibrosis in heart failure with preserved ejection fraction rats.
Wu X; Zhang T; Qiao J; Li C; Lin C; Xiong S
J Thorac Dis; 2022 Apr; 14(4):1157-1163. PubMed ID: 35572890
[TBL] [Abstract][Full Text] [Related]
31. Linggui Qihua Decoction Inhibits Atrial Fibrosis by Regulating TGF-
Xiong S; Shi Y; Liu J; Liu C; Yang L; Yang C; Dong G
Evid Based Complement Alternat Med; 2023; 2023():3764316. PubMed ID: 36820397
[TBL] [Abstract][Full Text] [Related]
32. Membrane rafts-redox signalling pathway contributes to renal fibrosis via modulation of the renal tubular epithelial-mesenchymal transition.
Han WQ; Xu L; Tang XF; Chen WD; Wu YJ; Gao PJ
J Physiol; 2018 Aug; 596(16):3603-3616. PubMed ID: 29863758
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin II stimulates apoptosis via TGF-beta1 signaling in ventricular cardiomyocytes of rat.
Schröder D; Heger J; Piper HM; Euler G
J Mol Med (Berl); 2006 Nov; 84(11):975-83. PubMed ID: 16924465
[TBL] [Abstract][Full Text] [Related]
34. Shenmai Injection Improves Hypertensive Heart Failure by Inhibiting Myocardial Fibrosis via TGF-β 1/Smad Pathway Regulation.
Hu SY; Zhou Y; Zhong SJ; Yang M; Huang SM; Li L; Li XC; Hu ZX
Chin J Integr Med; 2023 Feb; 29(2):119-126. PubMed ID: 35840852
[TBL] [Abstract][Full Text] [Related]
35. A rat model of metabolic syndrome-related heart failure with preserved ejection fraction phenotype: pathological alterations and possible molecular mechanisms.
Shi Y; Liu C; Yang C; Qiao W; Liu Y; Liu S; Dong G
Front Cardiovasc Med; 2023; 10():1208370. PubMed ID: 37469482
[TBL] [Abstract][Full Text] [Related]
36. Advance in the pharmacological and comorbidities management of heart failure with preserved ejection fraction: evidence from clinical trials.
Meifang W; Ying W; Wen C; Kaizu X; Meiyan S; Liming L
Heart Fail Rev; 2024 Mar; 29(2):305-320. PubMed ID: 37561223
[TBL] [Abstract][Full Text] [Related]
37. Myocardial fibrosis and prognosis in heart failure with preserved ejection fraction: a pooled analysis of 12 cohort studies.
Zhang X; Yang S; Hao S; Li J; Qiu M; Chen H; Huang Y
Eur Radiol; 2024 Mar; 34(3):1854-1862. PubMed ID: 37658896
[TBL] [Abstract][Full Text] [Related]
38. Zerumbone, a humulane sesquiterpene from Syringa pinnatifolia, attenuates cardiac fibrosis by inhibiting of the TGF-β1/Smad signaling pathway after myocardial infarction in mice.
Li J; Ge F; Wuken S; Jiao S; Chen P; Huang M; Gao X; Liu J; Tu P; Chai X; Huang L
Phytomedicine; 2022 Jun; 100():154078. PubMed ID: 35405613
[TBL] [Abstract][Full Text] [Related]
39. [The role of inflammation in heart failure with preserved ejection fraction].
Zhang Q; Chen YE; Zhu XX; Wang X; Qu AJ
Sheng Li Xue Bao; 2023 Jun; 75(3):390-402. PubMed ID: 37340648
[TBL] [Abstract][Full Text] [Related]
40. Respective roles of the mitogen-activated protein kinase (MAPK) family members in pancreatic stellate cell activation induced by transforming growth factor-β1 (TGF-β1).
Xu XF; Liu F; Xin JQ; Fan JW; Wu N; Zhu LJ; Duan LF; Li YY; Zhang H
Biochem Biophys Res Commun; 2018 Jun; 501(2):365-373. PubMed ID: 29705706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
